Low Contrast Strategies in TAVR: Feasibility and Outcomes to Prevent Renal Injury in Chronic Kidney Disease
We sought to evaluate the outcomes of a LC versus normal-contrast dose strategy in TAVR amongst patients with CKD.
Authors
- Tamim Nazif (ORCID: https://orcid.org/0000-0003-1239-2489)
- Susheel Kodali (ORCID: https://orcid.org/0000-0003-0517-2074)
- David Blusztein (ORCID: https://orcid.org/0000-0003-0907-5968)
- Paul Kurlansky (ORCID: https://orcid.org/0000-0003-2681-9885)
- Brigitte Kazzi (ORCID: https://orcid.org/0000-0002-8198-9089)
- Isaac George (ORCID: https://orcid.org/0000-0001-7770-4450)
- Rebecca T Hahn (ORCID: https://orcid.org/0000-0003-1342-9191)
- Chunhui Wang (ORCID: https://orcid.org/0000-0003-0370-4989)
- Yuming Ning (ORCID: https://orcid.org/0000-0002-0666-4145)
- Martin B. Leon (ORCID: https://orcid.org/0000-0002-2002-7492)
Institutions
- Brigham and Women's Hospital (US)
- Valve (United States) (US)
- NewYork–Presbyterian Hospital (US)
- Columbia University Irving Medical Center (US)
- Center for Innovation (US)
- Columbia University (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1002/ccd.31490
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00